Kolexia
Foa Cyril Oncologie médicale
Foa Cyril
Oncologie médicale
Clinique Chirurgicale De Martigues
Martigues, France
49 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs de l'endomètre Carcinomes Récidive tumorale locale Carcinome endométrioïde Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Tumeurs du poumon {{person.topmesh10.name}}

Collaborateurs

Voir plus
Paoli Jean-Baptiste
Paoli Jean-Baptiste
Clinique Chirurgicale De Martigues, Martigues, France
Ducournau Aurelie
Ducournau Aurelie
Clinique Chirurgicale De Martigues, Martigues, France
Thomas Georges
Thomas Georges
Cabinet libéral, Marseille, France
Escarguel Bruno
Escarguel Bruno
Cabinet libéral, Marseille, France

Industries

Voir plus
AstraZeneca
17 collaboration(s)
Dernière en 2023
Novartis
10 collaboration(s)
Dernière en 2022
Daiichi Sankyo
9 collaboration(s)
Dernière en 2023
MSD
6 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LBA42 Olaparib vs placebo as maintenance therapy after platinum-based chemotherapy in advanced/metastatic endometrial cancer patients: The GINECO randomized phase IIb UTOLA trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
APECS: Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast Cancer
Essai Clinique (Hôpital privé Dijon Bourgogne)   28 décembre 2022
Abstract P2-13-26: Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): First real-life data from the cohort temporary authorization for use (cATU) program in France
2021 San Antonio Breast Cancer Symposium   15 février 2022
LBA53 Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients (pts) treated with PD1/L1 immune checkpoint inhibitors (ICIs): A first analysis of the PIONeeR study
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma: The GINECO-UTOLA study.
2020 ASCO Annual Meeting I   25 mai 2020
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14).
Breast (Edinburgh, Scotland)   14 novembre 2019
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.
PloS one   18 octobre 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
British journal of cancer   10 janvier 2017
Prospective multicenter study of the impact of the Prosigna assay on adjuvant clinical decision-making in women with early stage breast cancer: which patients are the best candidates?
2016 ASCO Annual Meeting I   20 mai 2016
Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France.
PloS one   18 juin 2015